PERRONE, FRANCESCA PIA
 Distribuzione geografica
Continente #
EU - Europa 2.056
AS - Asia 1.462
NA - Nord America 1.414
SA - Sud America 122
AF - Africa 40
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 2
Totale 5.099
Nazione #
US - Stati Uniti d'America 1.370
DE - Germania 903
CN - Cina 451
GB - Regno Unito 402
SG - Singapore 396
IT - Italia 213
VN - Vietnam 206
HK - Hong Kong 146
SE - Svezia 132
RU - Federazione Russa 105
BD - Bangladesh 103
BR - Brasile 92
FR - Francia 66
IN - India 51
NL - Olanda 49
FI - Finlandia 47
IE - Irlanda 37
DK - Danimarca 34
CA - Canada 29
UA - Ucraina 25
CI - Costa d'Avorio 19
TR - Turchia 19
ID - Indonesia 18
ES - Italia 14
JP - Giappone 14
AR - Argentina 11
MX - Messico 11
UZ - Uzbekistan 8
EG - Egitto 7
PL - Polonia 6
KR - Corea 5
ZA - Sudafrica 5
AT - Austria 4
BE - Belgio 4
CO - Colombia 4
IQ - Iraq 4
JO - Giordania 4
SA - Arabia Saudita 4
AU - Australia 3
PE - Perù 3
PH - Filippine 3
PK - Pakistan 3
PY - Paraguay 3
VE - Venezuela 3
AE - Emirati Arabi Uniti 2
CZ - Repubblica Ceca 2
EC - Ecuador 2
GE - Georgia 2
KE - Kenya 2
KG - Kirghizistan 2
MM - Myanmar 2
MY - Malesia 2
NO - Norvegia 2
NP - Nepal 2
RO - Romania 2
TH - Thailandia 2
TN - Tunisia 2
TW - Taiwan 2
UY - Uruguay 2
AL - Albania 1
AO - Angola 1
AZ - Azerbaigian 1
BG - Bulgaria 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
ET - Etiopia 1
EU - Europa 1
GR - Grecia 1
IR - Iran 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LT - Lituania 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MK - Macedonia 1
MQ - Martinica 1
MU - Mauritius 1
NE - Niger 1
NG - Nigeria 1
OM - Oman 1
PA - Panama 1
SI - Slovenia 1
TJ - Tagikistan 1
TL - Timor Orientale 1
TM - Turkmenistan 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.099
Città #
Frankfurt am Main 819
Southend 372
Singapore 202
Ashburn 189
Hong Kong 138
Chandler 131
San Jose 100
Milan 75
Ho Chi Minh City 68
Beijing 63
Seattle 60
Princeton 56
Hanoi 49
Wilmington 49
Dallas 48
Fairfield 46
Council Bluffs 44
New York 42
Los Angeles 39
Dublin 37
Dearborn 35
Guangzhou 33
Santa Clara 33
Lauterbourg 29
Ann Arbor 28
Munich 27
Grafing 25
Nanjing 24
Buffalo 23
Helsinki 23
Bengaluru 22
Des Moines 22
Moscow 20
Abidjan 19
Houston 19
Cambridge 17
Shanghai 16
Istanbul 14
Tianjin 14
Woodbridge 14
Cangzhou 13
Phoenix 13
Hebei 12
Tokyo 12
Da Nang 11
Jakarta 11
Turku 11
Changsha 10
Columbus 10
Dong Ket 10
Hefei 10
Shenyang 10
Rome 9
São Paulo 9
Jinan 8
Nanchang 8
Shenzhen 8
Tashkent 8
The Dalles 8
Wuhan 8
Berlin 7
Fuzhou 7
Hangzhou 7
Ottawa 7
Toronto 7
Zhengzhou 7
Biên Hòa 6
Cairo 6
Chicago 6
Fremont 6
Haiphong 6
Montreal 6
Redwood City 6
Boardman 5
Dhaka 5
Edinburgh 5
Haikou 5
Nuremberg 5
San Diego 5
Shijiazhuang 5
Amman 4
Amsterdam 4
Baghdad 4
Brussels 4
Can Tho 4
Central District 4
Chennai 4
Jiaxing 4
London 4
Madrid 4
Mexico City 4
Phủ Lý 4
Andover 3
Bauru 3
Belo Horizonte 3
Boston 3
Brooklyn 3
Bến Tre 3
Charlotte 3
Curitiba 3
Totale 3.474
Nome #
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases 316
Intraperitoneal drain placement and outcomes after elective colorectal surgery: International matched, prospective, cohort study 274
Molecular and cytogenetic subgroups of oropharyngeal squamous cell carcinoma 265
Activity of temozolomide in patients with advanced chemorefractory colorectal cancer and MGMT promoter methylation 252
Toward the molecular dissection of peritoneal pseudomyxoma 250
TP53, P14ARF, P16INK4a and H-ras gene molecular analysis in intestinal-type adenocarcinoma of the nasal cavity and paranasal sinuses 243
Tumor stage, human papillomavirus and smoking status affect the survival of patients with oropharyngeal cancer : An Italian validation study 231
PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with Anti-Epidermal Growth Factor Receptor Agents 231
Prognostic and predictive value of EGFR in head and neck squamous cell carcinoma 220
GEN-O-MA project: an Italian network studying clinical course and pathogenic pathways of moyamoya disease—study protocol and preliminary results 219
Complete Response to Nivolumab in Recurrent/Metastatic HPV-Positive Head and Neck Squamous Cell Carcinoma Patient After Progressive Multifocal Leukoencephalopathy: A Case Report 218
A phase II study of sorafenib in recurrent and/or metastatic salivary gland carcinomas : Translational analyses and clinical impact 213
Identification of potentially druggable molecular alterations in skin adnexal malignancies 199
Functional genomics uncover the biology behind the responsiveness of head and neck squamous cell cancer patients to cetuximab 184
Correction: miR-451a is underexpressed and targets AKT/mTOR pathway in papillary thyroid carcinoma 177
Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs) 170
Evolutionary action score of TP53 coding variants is predictive of platinum response in head and neck cancer patients 168
Smoothened (SMO) receptor mutations dictate resistance tovismodegib in basal cell carcinoma 168
Tp53 status as guide for the management of ethmoid sinus intestinal-type adenocarcinoma 165
Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study 156
Risk factors for postoperative morbidity following appendectomy in the elderly: a nationwide prospective cohort study 155
Absence of ALK and MET alterations in head and neck sarcomatoid carcinoma 140
Oropharyngeal Squamous Cell Carcinoma Treated With Radiotherapy or Radiochemotherapy: Prognostic Role of TP53 and HPV Status 127
Role of EGFR family receptors in proliferation of squamous carcinoma cells induced by wound healing fluids of head and neck cancer patients 125
Prolonged response using gefitinib followed by sirolimus for advanced cutaneous squamous cell carcinoma 117
Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: A Tertiary Cancer Centre series analysis 94
Isolating p16-positive/HPV-negative Oropharyngeal Cancer : An Effort Worth Making 86
TP53 mutations and pathologic complete response to neoadjuvant cisplatin and fluorouracil chemotherapy in resected oral cavity squamous cell carcinoma 79
TP53 mutations in head and neck cancer 77
null 3
Totale 5.322
Categoria #
all - tutte 14.115
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.115


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202135 0 0 0 0 0 0 0 0 0 0 10 25
2021/2022251 32 10 4 7 9 11 15 8 23 49 14 69
2022/2023457 47 64 47 41 42 76 10 26 56 6 36 6
2023/2024807 8 26 18 19 96 33 118 102 58 101 109 119
2024/20251.037 108 119 89 115 53 45 28 81 64 69 80 186
2025/20261.647 201 82 167 110 134 85 309 61 156 118 224 0
Totale 5.322